Our objectives

RCT provides information on treatments, which it has investigated for evidence, by making the investigation results available to patients and physicians through the internet.

RCT participates in recognized research through organizations such as the Verelst Baarmoederkankerfonds Leuven (the Leuven-based Verelst foundation for uterine cancer). RCT will selectively provide funding for the clinical development of promising anti-cancer therapies/agents that fall outside the scope of established clinical cancer research. RCT will facilitate patient access to information regarding clinical trials which could be a treatment option.